Your browser doesn't support javascript.
loading
A Disintegrin and Metalloproteinase Domain-8: A Novel Protective Proteinase in Chronic Obstructive Pulmonary Disease.
Polverino, Francesca; Rojas-Quintero, Joselyn; Wang, Xiaoyun; Petersen, Hans; Zhang, Li; Gai, Xiaoyan; Higham, Andrew; Zhang, Duo; Gupta, Kushagra; Rout, Amit; Yambayev, Ilyas; Pinto-Plata, Victor; Sholl, Lynette M; Cunoosamy, Danen; Celli, Bartolomé R; Goldring, James; Singh, Dave; Tesfaigzi, Yohannes; Wedzicha, Jadwiga; Olsson, Henric; Owen, Caroline A.
Afiliación
  • Polverino F; 1 Division of Pulmonary and Critical Care Medicine and.
  • Rojas-Quintero J; 2 The Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
  • Wang X; 1 Division of Pulmonary and Critical Care Medicine and.
  • Petersen H; 1 Division of Pulmonary and Critical Care Medicine and.
  • Zhang L; 2 The Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
  • Gai X; 1 Division of Pulmonary and Critical Care Medicine and.
  • Higham A; 1 Division of Pulmonary and Critical Care Medicine and.
  • Zhang D; 3 Medicines Evaluation Unit, University of South Manchester NHS Foundation Trust, Manchester, United Kingdom.
  • Gupta K; 4 Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts.
  • Rout A; 1 Division of Pulmonary and Critical Care Medicine and.
  • Yambayev I; 1 Division of Pulmonary and Critical Care Medicine and.
  • Pinto-Plata V; 1 Division of Pulmonary and Critical Care Medicine and.
  • Sholl LM; 1 Division of Pulmonary and Critical Care Medicine and.
  • Cunoosamy D; 5 Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Celli BR; 6 Respiratory, Inflammation and Autoimmunity Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Goldring J; 1 Division of Pulmonary and Critical Care Medicine and.
  • Singh D; 2 The Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
  • Tesfaigzi Y; 7 Royal Free Hospital, London, United Kingdom; and.
  • Wedzicha J; 3 Medicines Evaluation Unit, University of South Manchester NHS Foundation Trust, Manchester, United Kingdom.
  • Olsson H; 2 The Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
  • Owen CA; 8 Imperial College London, National Heart and Lung Institute, London, United Kingdom.
Am J Respir Crit Care Med ; 198(10): 1254-1267, 2018 11 15.
Article en En | MEDLINE | ID: mdl-29750543
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígenos CD / Enfermedad Pulmonar Obstructiva Crónica / Proteínas ADAM / Proteínas de la Membrana Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígenos CD / Enfermedad Pulmonar Obstructiva Crónica / Proteínas ADAM / Proteínas de la Membrana Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos